MEP5808A - Ecitalopram bromhidrat i postupak za njegovo pripremanje - Google Patents

Ecitalopram bromhidrat i postupak za njegovo pripremanje

Info

Publication number
MEP5808A
MEP5808A MEP-58/08A MEP5808A MEP5808A ME P5808 A MEP5808 A ME P5808A ME P5808 A MEP5808 A ME P5808A ME P5808 A MEP5808 A ME P5808A
Authority
ME
Montenegro
Prior art keywords
preparation
escitalopram hydrobromide
escitalopram
hydrobromide
citalopram
Prior art date
Application number
MEP-58/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Lawrence Martel
Robert Dancer
Hans Petersen
Peter Ellegaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32668635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP5808(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MEP5808A publication Critical patent/MEP5808A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MEP-58/08A 2002-12-23 2003-12-18 Ecitalopram bromhidrat i postupak za njegovo pripremanje MEP5808A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202005 2002-12-23
PCT/DK2003/000902 WO2004056791A1 (en) 2002-12-23 2003-12-18 Escitalopram hydrobromide and a method for the preparation thereof

Publications (1)

Publication Number Publication Date
MEP5808A true MEP5808A (xx) 2010-02-10

Family

ID=32668635

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-58/08A MEP5808A (xx) 2002-12-23 2003-12-18 Ecitalopram bromhidrat i postupak za njegovo pripremanje

Country Status (33)

Country Link
US (1) US20040167209A1 (es)
EP (1) EP1578738B1 (es)
JP (2) JP4658613B2 (es)
KR (1) KR20050086933A (es)
CN (1) CN100349885C (es)
AR (1) AR042652A1 (es)
AT (1) ATE388947T1 (es)
AU (1) AU2003287919B2 (es)
BR (1) BR0317623A (es)
CA (1) CA2511142A1 (es)
CY (1) CY1107451T1 (es)
DE (1) DE60319739T2 (es)
DK (1) DK1578738T3 (es)
EA (1) EA013116B1 (es)
EG (1) EG24729A (es)
ES (1) ES2298595T3 (es)
HK (1) HK1087708A1 (es)
IL (1) IL169125A0 (es)
IS (1) IS2654B (es)
ME (1) MEP5808A (es)
MX (1) MXPA05005772A (es)
MY (1) MY135468A (es)
NO (1) NO20053595L (es)
NZ (1) NZ540281A (es)
PE (1) PE20040924A1 (es)
PL (1) PL378275A1 (es)
PT (1) PT1578738E (es)
RS (1) RS51092B (es)
TW (1) TW200501943A (es)
UA (1) UA80170C2 (es)
UY (1) UY28148A1 (es)
WO (1) WO2004056791A1 (es)
ZA (1) ZA200504109B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
PT1578738E (pt) * 2002-12-23 2008-04-11 Lundbeck & Co As H Bromidrato de escitalopram e um método para a sua preparação
WO2005084643A1 (en) * 2004-03-05 2005-09-15 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US20070112075A1 (en) * 2005-10-14 2007-05-17 Forest Laboratories, Inc. Stable pharmaceutical formulations containing escitalopram and bupropion
BRPI0617382A2 (pt) * 2005-10-14 2017-07-11 H Lundbeck As Métodos para tratar um distúrbio do sistema nervoso central em um paciente, para tratar um paciente sofrendo de condições e uma disfunção sexual, e para reduzir um retardo na eficácia terapêutica em seguida ao início do tratamento
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
JP5501615B2 (ja) * 2006-07-11 2014-05-28 田辺三菱製薬株式会社 モルホリン化合物の塩
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FR3006594A1 (fr) * 2013-06-11 2014-12-12 Sorin Crm Sas Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) * 2017-06-05 2022-12-06 上海奥博生物医药股份有限公司 一种艾司西酞普兰双羟萘酸盐新的制备方法
PL3694843T3 (pl) * 2017-10-09 2022-06-20 Hasleton, Mark Nowa sól i nowe stałe postacie escitalopramu
US20240100012A1 (en) 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34712A (en) * 1862-03-18 James h
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
KR100411505B1 (ko) * 1998-10-20 2003-12-18 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
DE69920526T2 (de) * 1999-10-25 2006-02-23 H. Lundbeck A/S Verfahren zur herstellung von citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
JP2002020379A (ja) * 2000-05-02 2002-01-23 Sumika Fine Chemicals Co Ltd シタロプラム臭化水素酸塩の結晶およびその結晶化方法
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
WO2002046339A2 (de) * 2000-12-04 2002-06-13 Dr. Frische Gmbh Verfahren zur vorbehandlung von rohölen und rohfetten für eine herstellung von fettsäureestern
EA200301195A1 (ru) * 2001-05-01 2004-04-29 Х. Лундбекк А/С Применение энантиомерно чистого эсциталопрама
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
PT1578738E (pt) * 2002-12-23 2008-04-11 Lundbeck & Co As H Bromidrato de escitalopram e um método para a sua preparação
US20050174782A1 (en) * 2003-03-25 2005-08-11 Chapman Leonard T. Flashlight

Also Published As

Publication number Publication date
BR0317623A (pt) 2005-11-29
DK1578738T3 (da) 2008-06-30
PT1578738E (pt) 2008-04-11
IS2654B (is) 2010-08-15
DE60319739T2 (de) 2008-07-17
TW200501943A (en) 2005-01-16
HK1087708A1 (en) 2006-10-20
WO2004056791A1 (en) 2004-07-08
NO20053595L (no) 2005-09-05
PL378275A1 (pl) 2006-03-20
UA80170C2 (en) 2007-08-27
DE60319739D1 (de) 2008-04-24
RS51092B (sr) 2010-10-31
ES2298595T3 (es) 2008-05-16
EG24729A (en) 2010-06-21
CY1107451T1 (el) 2012-12-19
US20040167209A1 (en) 2004-08-26
IS7848A (is) 2005-05-17
AU2003287919B2 (en) 2009-11-12
UY28148A1 (es) 2004-09-30
PE20040924A1 (es) 2004-12-11
MY135468A (en) 2008-04-30
ATE388947T1 (de) 2008-03-15
CA2511142A1 (en) 2004-07-08
JP2011037893A (ja) 2011-02-24
RS20050487A (en) 2007-06-04
AU2003287919A1 (en) 2004-07-14
MXPA05005772A (es) 2005-08-16
NZ540281A (en) 2008-07-31
EA200501046A1 (ru) 2005-12-29
EP1578738B1 (en) 2008-03-12
CN1726202A (zh) 2006-01-25
ZA200504109B (en) 2006-08-30
EP1578738A1 (en) 2005-09-28
CN100349885C (zh) 2007-11-21
KR20050086933A (ko) 2005-08-30
JP4658613B2 (ja) 2011-03-23
EA013116B1 (ru) 2010-02-26
JP2006514952A (ja) 2006-05-18
AR042652A1 (es) 2005-06-29
IL169125A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
CY1107451T1 (el) Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου
MXPA03005222A (es) Derivado de metanosulfonamido-benzofurano, su procedimiento de preparacion y su utilizacion como intermediario de sisntesis.
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
ZA200106683B (en) Method for the preparation of citalopram.
ZA200206699B (en) Method for the preparation of citalopram.
AP1703A (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same.
MXPA04001785A (es) Benzofurano y derivados de dihidrobenzofurano utiles como agonistas de beta-3 adrenoreceptores.
MXPA02009275A (es) Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.
ZA200309471B (en) Method for the preparation of escitalopram.
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
AU2002225369A1 (en) Photobase generators, curable compositions prepared by using the same and process of curing
ZA200403432B (en) Method for the preparation of escitalopram.
AU2002305344A1 (en) Ortho-alkylphenol derived mannich detergent composition and concentrate, fuel and method thereof
HK1052512A1 (en) Method for the preparation of citalopram
AU2003218824A1 (en) Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
MXPA03004431A (es) Nuevas composiciones farmaceuticas con accion antidiabetica y proceso para su preparacion.
AU2003246840A8 (en) Anti-hiv composition, production method thereof and medicament
AU2002245649A1 (en) Methods, compositions and kits for preserving antigenicity
MX2021010511A (es) Procedimiento para preparar un compuesto tricíclico fusionado, e intermedio del mismo.
AU2001270741A1 (en) Steel compositions, method for obtaining same and parts made from same
WO2002004017A3 (en) Method for preparing oral vaccines
HRP20070517A2 (en) Escitalopram hydrobromide and a method for the preparation thereof
BG106958A (en) Method for the preparation of citalopram
AU2002304614A1 (en) Compositions for non-polluting fuels, preparation processes and use thereof